Steven Cohen Clene Inc. Transaction History
Point72 Asset Management, L.P.
- $36 Billion
- Q2 2024
A detailed history of Steven Cohen (Point72 Asset Management, L.P.) transactions in Clene Inc. stock. As of the latest transaction made, Point72 Asset Management, L.P. holds 150,400 shares of CLNN stock, worth $797,120. This represents 0.0% of its overall portfolio holdings.
Number of Shares
150,400Holding current value
$797,120% of portfolio
0.0%Shares
0 transactions
Quarter | Operation | Price Per share | shares change | shares Held | SEC Form |
---|
Others Institutions Holding CLNN
# of Institutions
47Shares Held
6.9MCall Options Held
287KPut Options Held
162K-
Vanguard Group Inc Valley Forge, PA2.62MShares$13.9 Million0.0% of portfolio
-
Geode Capital Management, LLC Boston, MA922KShares$4.88 Million0.0% of portfolio
-
Lunt Capital Management, Inc. Holladay, UT591KShares$3.13 Million0.1% of portfolio
-
Scoggin Management LP New York, NY375KShares$1.99 Million0.05% of portfolio
-
Morgan Stanley New York, NY339KShares$1.79 Million0.0% of portfolio
About Clene Inc.
- Ticker CLNN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 63,502,000
- Market Cap $337M
- Description
- Clene Inc., a clinical-stage pharmaceutical company, focuses on the discovery, development, and commercialization of novel clean-surfaced nanotechnology (CSN) therapeutics. Its lead drug is CNM-Au8, which is being studied in various clinical trials, including a Phase 2/3 registrational clinical trial for patients with amyotrophic lateral scleros...